SCHEMBL22148759

SCHEMBL22148759

c1ccc(-c2cc(-c3ccccc3)nc(-c3ccccc3-c3c(-n4c5ccccc5c5ccccc54)c(-n4c5ccccc5c5ccccc54)nc(-n4c5ccccc5c5ccccc54)c3-n3c4ccccc4c4ccccc43)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.37
KMT2A Q03164 7/20 0.37
MAPT P10636 6/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
LMNA P02545 3/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
MAPK10 P53779 1/20 0.37
HPGD P15428 4/20 0.35
ALDH1A1 P00352 3/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
ADORA2A P29274 2/20 0.35
ADORA1 P30542 2/20 0.35
NTSR1 P30989 1/20 0.35
AGTR1 P30556 2/20 0.35
CYP3A4 P08684 1/20 0.35
GAA P10253 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30709437 1.00 MEN1 (0.37) MEN1KMT2AMAPTSMN1; SMN2LMNA
SCHEMBL22148591 0.92 MEN1 (0.39) MEN1KMT2AMAPTSMN1; SMN2LMNA
SCHEMBL22148530 0.91 TNF (0.33) MEN1KMT2AMAPTSMN1; SMN2LMNA
SCHEMBL22148917 0.91 MAOA (0.36) MEN1KMT2AMAPTSMN1; SMN2LMNA
SCHEMBL30709206 0.91 MAOA (0.36) MEN1KMT2AMAPTSMN1; SMN2LMNA
SCHEMBL22148660 0.91 MAOA (0.36) MEN1KMT2AMAPTSMN1; SMN2LMNA
SCHEMBL22148776 0.90 SMN1; SMN2 (0.35) MEN1KMT2AMAPTSMN1; SMN2LMNA
SCHEMBL30709490 0.90 SMN1; SMN2 (0.35) MEN1KMT2AMAPTSMN1; SMN2LMNA
SCHEMBL22148545 0.89 TSHR (0.36) MEN1KMT2AMAPTSMN1; SMN2TDP1
SCHEMBL21888587 0.89 MEN1 (0.39) MEN1KMT2AMAPTSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200203622-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200203622-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES NDUFV3, NDUFV2, CRY2 MEN1 2193/4885KMT2A 4367/4885MAPT 275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.